U.S. Oil and Gas Stock News

ImmunityBio reported updated Phase 2 data from its QUILT-3.078 trial of ANKTIVA plus CAR-NK therapy in recurrent glioblastoma. The combination showed a median overall survival that has not yet been reached, with most patients still alive and maintaining immune function. The regimen was reported to have a manageable safety profile and did not require chemotherapy. For ImmunityBio (NasdaqGS:IBRX), this new glioblastoma update lands at a time when the stock has already logged sharp moves. The...

The board of South Plains Financial, Inc. ( NASDAQ:SPFI ) has announced that it will be paying its dividend of $0.17 on...

Why Community Financial System is on investors’ radar Community Financial System (CBU) has drawn attention after recent share price moves, with the stock showing a mix of short term softness and longer term gains across the past week, month, and past 3 months. See our latest analysis for Community Financial System. At a share price of $61.77, Community Financial System has paired a 30 day share price return of 4.62% with a 90 day gain of 7.69%, while the 1 year total shareholder return of a...

Why Fastenal Is On Investors’ Radar Today Fastenal (FAST) is back in focus after a recent market move that left its shares with a 1 day return of about a 0.4% decline, while month and past 3 months returns remain slightly positive. See our latest analysis for Fastenal. At a share price of $43.73, Fastenal’s recent 5.2% 1 month share price return and 8.1% year to date share price return sit alongside a 1 year total shareholder return of 17.1%, pointing to momentum that has been steady rather...

Flowserve (NYSE:FLS) has seen a substantial increase in insider selling activity, including recent stock sales by the CEO. Multiple insiders have reduced their holdings over a short period, drawing fresh attention to management trading behavior. These transactions are material for investors who track insider sentiment as part of their process. Flowserve, trading at $77.75, has caught investors' attention not only for its operations but also for its recent share price performance. The stock...

American Eagle Outfitters (NYSE:AEO) is closing its Quiet Logistics business, leading to fulfillment center closures and layoffs. The company acquired Quiet Logistics in 2021 and is now winding it down as part of a shift in how it manages order fulfillment. At the same time, American Eagle Outfitters is launching a five year global ambassador partnership with international football player Lamine Yamal. The Quiet Logistics exit and the high profile marketing deal are expected to influence how...

On 22 January 2026, Barclays announced a multiyear arrangement with FactSet Research Systems to use FactSet’s advanced analytics, data, and technology platforms across its global operations. The deal underscores FactSet’s role as a core infrastructure provider to major financial institutions, reinforcing its position in mission-critical market data and analytics workflows. Next, we’ll consider how this Barclays partnership, particularly the broad access to FactSet’s analytics suite, reshapes...

Cal-Maine Foods (CALM) is back in focus after reporting 18.5% annual revenue growth over the last three years and 34.7% annual earnings per share growth, supported by share buybacks and strong free cash flow. See our latest analysis for Cal-Maine Foods. The recent earnings update comes as Cal-Maine Foods’ share price shows mixed momentum, with a 1-day share price return of 2.32% and 7-day share price return of 5.70%, but a 1-year total shareholder return of 17.77% decline and a 5-year total...

The recent price decline of 11% in GEN Restaurant Group, Inc.'s ( NASDAQ:GENK ) stock may have disappointed insiders...

Plumas Bancorp's ( NASDAQ:PLBC ) dividend will be increasing from last year's payment of the same period to $0.33 on...

Affirm Holdings (NasdaqGS:AFRM) announced an exclusive collaboration with Fiserv to bring pay over time features to debit cards for thousands of financial institutions. The company has applied to form Affirm Bank, an FDIC insured subsidiary, in a move that would place it under direct banking regulation. The Fiserv partnership is designed to let banks and credit unions offer Affirm powered installment options without adding major technical complexity. Affirm runs a buy now, pay later model...

NCR Atleos recently appointed Rohan Pal as Chief Information Officer, bringing more than 25 years of experience in IT modernization, cybersecurity, cloud solutions and digital product development to support its innovation and operational goals. His track record driving digital transformation at companies such as WillScot, ServiceNow, Brinks and Home Depot underscores how technology leadership is becoming central to Atleos’ long-term service and automation ambitions. Next, we’ll explore how...

Dominion Energy’s board recently declared a quarterly dividend of US$0.6675 per share, payable on March 20, 2026, to shareholders of record as of February 27, 2026, while a federal court allowed construction to resume on its Coastal Virginia Offshore Wind project. The court’s preliminary injunction revives a 2.6-gigawatt offshore wind development expected to supply power to up to 660,000 homes, reinforcing Dominion Energy’s diverse supply approach. We’ll now look at how the resumption of...

Why HEICO Stock Is Back on Investors’ Radar HEICO (HEI) has caught investor attention again after recent share price moves, including a roughly 5% decline over the past week and a small gain over the past month. See our latest analysis for HEICO. While the 7 day share price return of 4.65% and a modest move over the past month suggest some cooling after a stronger 90 day gain of 7.55%, the 1 year total shareholder return of 42.89% and 5 year total shareholder return of 183.49% show that...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Guidewire Software (GWRE) is back in focus after a mixed earnings reaction, where solid revenue and EBITDA beats met a cautious full year outlook, even as new cloud partnerships and international customer go lives continue to roll out. See our latest analysis for Guidewire Software. At a share price of US$161.89, Guidewire’s 1 day and 7 day share price returns of 1.16% and 1.82% follow a sharp 30 day and 90 day share price decline of 21.21% and 36.02%. This comes even as cloud go lives and...

Mirum Pharmaceuticals: Recent Stock Performance in Focus Mirum Pharmaceuticals (MIRM) has caught investor attention after a strong run over the past month and past 3 months, prompting a closer look at how its rare disease portfolio and current financial profile line up. See our latest analysis for Mirum Pharmaceuticals. The recent move to a US$96.92 share price sits within a strong run, with a 30-day share price return of 22.28% and a one year total shareholder return of 99.92%. This points...

Coupang (NYSE:CPNG) reported a large-scale data breach affecting tens of millions of customer accounts. Multiple class action lawsuits have been filed in response to the incident. A CEO has resigned following the breach and its fallout. Regulators in South Korea have opened heightened investigations into the company. Major U.S. shareholders have petitioned the U.S. government for intervention under international trade agreements. Coupang, the South Korea based e-commerce company listed on...

Rivian Automotive has begun rolling out R2 validation units as part of its next phase of production. The company is working on cost reduction initiatives and updating factory infrastructure alongside R2 validation. These steps indicate operational progress ahead of the planned introduction of the new R2 model. Rivian Automotive, listed as NasdaqGS:RIVN, is moving the R2 program forward while its shares most recently traded at $15.75. The stock has seen a 23.9% gain over the past year, while...

If you are wondering whether Haemonetics shares are offering real value right now, it helps to start by separating price moves from what the underlying business might be worth. The stock last closed at US$68.37, with returns of 5.3% decline over 7 days, 14.8% decline over 30 days, 14.5% decline year to date, 4.1% decline over 1 year, 18.8% decline over 3 years and 40.5% decline over 5 years. These figures may prompt questions about how the current price lines up with fundamentals. Recent...

In its latest quarter, Marvell Technology reported record fiscal 2026 third‑quarter results and agreed to acquire XConn Technologies for about US$540 million to enhance its PCIe and CXL switching portfolio for data‑center and AI infrastructure. At the same time, broader semiconductor sentiment weakened after Intel highlighted ongoing supply shortages and a softer sector outlook, pulling Marvell into industry‑wide concern despite its strong AI‑related positioning. With recent gains in the...

If you are wondering whether Thermo Fisher Scientific at around US$626 per share still offers value, you are not alone. A closer look at its current pricing can help frame that question. The stock has returned 1.3% over the last week, 7.9% over the last month, 5.8% year to date, 7.7% over one year, 12.0% over three years, and 23.2% over five years, which gives useful context before assessing what you are paying today. Recent coverage has focused on Thermo Fisher Scientific's position as a...

Apellis Pharmaceuticals (NasdaqGS:APLS) reports GAAP profitability as it ramps commercial sales of Syfovre. The company shifts from a primarily clinical stage focus to a commercial model centered on its approved therapy for geographic atrophy. This transition marks a new phase for Apellis as a growth stage biotech with revenue tied directly to product sales. For you as an investor, the key point is that Apellis has moved from relying mainly on development activities to generating revenue...

Key Insights Significant insider control over Dogness (International) implies vested interests in company growth The...